|
Target organ
|
OD
|
SD
|
ED contribution
|
SD
|
|---|
|
(mSv/MBq)
|
(mSv/MBq)
|
|---|
|
Adrenals
|
1.30E−02
|
2.26E−03
|
1.12E−04
|
1.94E−05
|
|
Brain
|
2.86E−02
|
3.33E−03
|
2.86E−04
|
3.33E−05
|
|
Breasts
|
6.29E−03
|
3.86E−04
|
7.55E−04
|
4.63E−05
|
|
Gallbladder wall
|
2.34E−02
|
9.30E−03
|
2.01E−04
|
7.99E−05
|
|
LLI wall
|
1.67E−02
|
2.89E−03
|
1.00E−03
|
1.74E−04
|
|
Small intestine
|
2.94E−02
|
8.90E−03
|
2.53E−04
|
7.66E−05
|
|
Stomach wall
|
2.04E−02
|
3.89E−03
|
2.44E−03
|
4.67E−04
|
|
ULI wall
|
3.24E−02
|
1.02E−02
|
1.94E−03
|
6.14E−04
|
|
Heart wall
|
1.57E−02
|
1.65E−03
|
1.35E−04
|
1.42E−05
|
|
Kidneys
|
3.81E−02
|
4.52E−03
|
3.28E−04
|
3.89E−05
|
|
Liver
|
5.31E−02
|
2.98E−02
|
2.12E−03
|
1.19E−03
|
|
Lungs
|
2.70E−02
|
2.60E−03
|
3.24E−03
|
3.12E−04
|
|
Muscle
|
7.90E−03
|
1.26E−04
|
6.80E−05
|
1.08E−06
|
|
Ovaries
|
1.31E−02
|
1.22E−03
|
1.05E−03
|
9.73E−05
|
|
Pancreas
|
2.08E−02
|
4.11E−03
|
1.79E−04
|
3.53E−05
|
|
Red marrow
|
1.49E−02
|
8.50E−04
|
1.79E−03
|
1.02E−04
|
|
Osteogenic cells
|
1.42E−02
|
7.81E−04
|
1.42E−04
|
7.81E−06
|
|
Skin
|
5.52E−03
|
1.27E−04
|
5.52E−05
|
1.27E−06
|
|
Spleen
|
1.34E−02
|
4.19E−03
|
1.15E−04
|
3.60E−05
|
|
Testes
|
2.17E−02
|
1.21E−02
|
1.53E−03
|
1.33E−03
|
|
Thymus
|
7.48E−03
|
2.91E−04
|
6.43E−05
|
2.50E−06
|
|
Thyroid
|
2.29E−02
|
4.37E−03
|
9.17E−04
|
1.75E−04
|
|
Urinary bladder wall
|
1.02E−01
|
2.96E−02
|
4.09E−03
|
1.18E−03
|
|
Uterus
|
1.55E−02
|
1.71E−03
|
1.33E−04
|
1.47E−05
|
|
Total body
|
1.05E−02
|
8.42E−04
|
–
|
–
|
|
ED (mSv/MBq)
| | |
2.30E−02
|
1.91E−03
|
|
ED (mSv/MBq) ICRP 60
| |
2.48E−02
|
1.18E−03
|
- ODs calculated for the adult male model (73.7 kg, implemented in OLINDA)
-
OD organ dose, ED effective dose (ICRP 103), SD standard deviation mean over three human subjects
